Peachtree Investment Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Peachtree Investment Advisors's PFE Position: Q4 2018 in Review
Peachtree Investment Advisors increased its Pfizer (PFE) stake by 24% in Q4 2018, buying an estimated $170K and bringing the position to 20,839 shares worth $863K. The position accounts for 0.67% of the portfolio, ranked #33.
Peachtree Investment Advisors first reported a position in PFE in Q4 2013 and has held it in 21 quarters since. 2,403 funds tracked by Wall St. Rank hold PFE as of Q4 2018.
- Peachtree Investment Advisors held 20,839 shares of Pfizer worth $863K as of Q4 2018.
- Peachtree Investment Advisors bought 4,085 Pfizer shares in Q4 2018, an estimated $170K.
- Pfizer made up 0.67% of Peachtree Investment Advisors's portfolio in Q4 2018, its #33 holding.
- Peachtree Investment Advisors first reported a position in Pfizer in Q4 2013 and has held it in 21 quarters since.
- 2,403 funds tracked by Wall St. Rank held Pfizer as of Q4 2018.
Based on Peachtree Investment Advisors's 13F filing for Q4 2018, filed 14 Jan 2019.